0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Vaccine Market Insights and Forecast to 2027
Published Date: June 2021
|
Report Code: QYRE-Othe-4139
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Influenza Vaccine Market Insights and Forecast to 2027

Global Influenza Vaccine Market Insights and Forecast to 2027

Code: QYRE-Othe-4139
Report
June 2021
119 Pages
QYResearch
Region: North America, Asia Pacific, Europe, South America, Africa, Middle East, Global,
Description
Table of Content
Tables & Figures
Influenza Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines

Segment by Application

For Children (6 months to 3 years)
For Adults and Children over 3 years

BY COMPANY

CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
1 Study Coverage
1.1 Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type
1.4.2 Whole Virus Vaccines
1.4.3 Split Virus Vaccines
1.2.4 Subunit Vaccines
1.2.5 Live Attenuated Virus Vaccines
1.3 Market by Application
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Vaccine Sales Estimates and Forecasts 2016-2027
2.2 Global Influenza Vaccine Revenue Estimates and Forecasts 2016-2027
2.3 Global Influenza Vaccine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Influenza Vaccine Regions by Sales
2.4.1 Global Top Influenza Vaccine Regions by Sales (2016-2021)
2.4.2 Global Top Influenza Vaccine Regions by Sales (2022-2027)
2.5 Global Top Influenza Vaccine Regions by Revenue
2.5.1 Global Top Influenza Vaccine Regions by Revenue (2016-2021)
2.5.2 Global Top Influenza Vaccine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Influenza Vaccine Sales by Manufacturers
3.1.1 Global Top Influenza Vaccine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Influenza Vaccine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Influenza Vaccine Sales in 2020
3.2 Global Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Top Influenza Vaccine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Influenza Vaccine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Influenza Vaccine Revenue in 2020
3.3 Global Influenza Vaccine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Influenza Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Influenza Vaccine Sales by Type
4.1.1 Global Influenza Vaccine Historical Sales by Type (2016-2021)
4.1.2 Global Influenza Vaccine Forecasted Sales by Type (2022-2027)
4.1.3 Global Influenza Vaccine Sales Market Share by Type (2016-2027)
4.2 Global Influenza Vaccine Revenue by Type
4.2.1 Global Influenza Vaccine Historical Revenue by Type (2016-2021)
4.2.2 Global Influenza Vaccine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Influenza Vaccine Revenue Market Share by Type (2016-2027)
4.3 Global Influenza Vaccine Price by Type
4.3.1 Global Influenza Vaccine Price by Type (2016-2021)
4.3.2 Global Influenza Vaccine Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Influenza Vaccine Sales by Application
5.1.1 Global Influenza Vaccine Historical Sales by Application (2016-2021)
5.1.2 Global Influenza Vaccine Forecasted Sales by Application (2022-2027)
5.1.3 Global Influenza Vaccine Sales Market Share by Application (2016-2027)
5.2 Global Influenza Vaccine Revenue by Application
5.2.1 Global Influenza Vaccine Historical Revenue by Application (2016-2021)
5.2.2 Global Influenza Vaccine Forecasted Revenue by Application (2022-2027)
5.2.3 Global Influenza Vaccine Revenue Market Share by Application (2016-2027)
5.3 Global Influenza Vaccine Price by Application
5.3.1 Global Influenza Vaccine Price by Application (2016-2021)
5.3.2 Global Influenza Vaccine Price Forecast by Application (2022-2027)
6 North America
6.1 North America Influenza Vaccine Market Size by Type
6.1.1 North America Influenza Vaccine Sales by Type (2016-2027)
6.1.2 North America Influenza Vaccine Revenue by Type (2016-2027)
6.2 North America Influenza Vaccine Market Size by Application
6.2.1 North America Influenza Vaccine Sales by Application (2016-2027)
6.2.2 North America Influenza Vaccine Revenue by Application (2016-2027)
6.3 North America Influenza Vaccine Market Size by Country
6.3.1 North America Influenza Vaccine Sales by Country (2016-2027)
6.3.2 North America Influenza Vaccine Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Influenza Vaccine Market Size by Type
7.1.1 Europe Influenza Vaccine Sales by Type (2017-2027)
7.1.2 Europe Influenza Vaccine Revenue by Type (2017-2027)
7.2 Europe Influenza Vaccine Market Size by Application
7.2.1 Europe Influenza Vaccine Sales by Application (2017-2027)
7.2.2 Europe Influenza Vaccine Revenue by Application (2017-2027)
7.3 Europe Influenza Vaccine Market Size by Country
7.3.1 Europe Influenza Vaccine Sales by Country (2017-2027)
7.3.2 Europe Influenza Vaccine Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Influenza Vaccine Market Size by Type
8.1.1 Asia Pacific Influenza Vaccine Sales by Type (2018-2027)
8.1.2 Asia Pacific Influenza Vaccine Revenue by Type (2018-2027)
8.2 Asia Pacific Influenza Vaccine Market Size by Application
8.2.1 Asia Pacific Influenza Vaccine Sales by Application (2018-2027)
8.2.2 Asia Pacific Influenza Vaccine Revenue by Application (2018-2027)
8.3 Asia Pacific Influenza Vaccine Market Size by Region
8.3.1 Asia Pacific Influenza Vaccine Sales by Region (2018-2027)
8.3.2 Asia Pacific Influenza Vaccine Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Influenza Vaccine Market Size by Type
9.1.1 Latin America Influenza Vaccine Sales by Type (2019-2027)
9.1.2 Latin America Influenza Vaccine Revenue by Type (2019-2027)
9.2 Latin America Influenza Vaccine Market Size by Application
9.2.1 Latin America Influenza Vaccine Sales by Application (2019-2027)
9.2.2 Latin America Influenza Vaccine Revenue by Application (2019-2027)
9.3 Latin America Influenza Vaccine Market Size by Country
9.3.1 Latin America Influenza Vaccine Sales by Country (2019-2027)
9.3.2 Latin America Influenza Vaccine Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Influenza Vaccine Market Size by Type
6.1.1 Middle East and Africa Influenza Vaccine Sales by Type (2016-2027)
6.1.2 Middle East and Africa Influenza Vaccine Revenue by Type (2016-2027)
6.2 Middle East and Africa Influenza Vaccine Market Size by Application
6.2.1 Middle East and Africa Influenza Vaccine Sales by Application (2016-2027)
6.2.2 Middle East and Africa Influenza Vaccine Revenue by Application (2016-2027)
6.3 Middle East and Africa Influenza Vaccine Market Size by Country
6.3.1 Middle East and Africa Influenza Vaccine Sales by Country (2016-2027)
6.3.2 Middle East and Africa Influenza Vaccine Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Overview
11.1.3 CSL Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 CSL Influenza Vaccine Product Description
11.1.5 CSL Related Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 GSK Influenza Vaccine Product Description
11.2.5 GSK Related Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Sanofi Pasteur Influenza Vaccine Product Description
11.3.5 Sanofi Pasteur Related Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Mylan Influenza Vaccine Product Description
11.4.5 Mylan Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 AstraZeneca Influenza Vaccine Product Description
11.5.5 AstraZeneca Related Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Pfizer Influenza Vaccine Product Description
11.6.5 Pfizer Related Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Johnson & Johnson Influenza Vaccine Product Description
11.7.5 Johnson & Johnson Related Developments
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Overview
11.1.3 CSL Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 CSL Influenza Vaccine Product Description
11.1.5 CSL Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Influenza Vaccine Value Chain Analysis
12.2 Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza Vaccine Production Mode & Process
12.4 Influenza Vaccine Sales and Marketing
12.4.1 Influenza Vaccine Sales Channels
12.4.2 Influenza Vaccine Distributors
12.5 Influenza Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Influenza Vaccine Industry Trends
13.2 Influenza Vaccine Market Drivers
13.3 Influenza Vaccine Market Challenges
13.4 Influenza Vaccine Market Restraints
14 Key Findings in The Global Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Influenza Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Whole Virus Vaccines
    Table 3. Major Manufacturers of Split Virus Vaccines
    Table 4. Major Manufacturers of Subunit Vaccines
    Table 5. Major Manufacturers of Live Attenuated Virus Vaccines
    Table 6. Global Influenza Vaccine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 7. Global Influenza Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 8. Global Influenza Vaccine Sales by Region (2016-2021) & (K Doses)
    Table 9. Global Influenza Vaccine Sales Market Share by Region (2016-2021)
    Table 10. Global Influenza Vaccine Sales by Region (2016-2021) & (K Doses)
    Table 11. Global Influenza Vaccine Sales Market Share by Region (2022-2027)
    Table 12. Global Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 13. Global Influenza Vaccine Revenue Market Share by Region (2016-2021)
    Table 14. Global Influenza Vaccine Revenue by Region (2022-2027) & (US$ Million)
    Table 15. Global Influenza Vaccine Revenue Market Share by Region (2022-2027)
    Table 16. Global Influenza Vaccine Sales by Manufacturers (2016-2021) & (K Doses)
    Table 17. Global Influenza Vaccine Sales Share by Manufacturers (2016-2021)
    Table 18. Global Influenza Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 19. Global Influenza Vaccine Revenue Share by Manufacturers (2016-2021)
    Table 20. Influenza Vaccine Price by Manufacturers 2016-2021 (USD/Doses)
    Table 21. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2020)
    Table 23. Influenza Vaccine Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Influenza Vaccine Product Offered
    Table 25. Date of Manufacturers Enter into Influenza Vaccine Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
    Table 28. Global Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
    Table 29. Global Influenza Vaccine Sales Share by Type (2016-2021)
    Table 30. Global Influenza Vaccine Sales Share by Type (2022-2027)
    Table 31. Global Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 32. Global Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
    Table 33. Global Influenza Vaccine Revenue Share by Type (2016-2021)
    Table 34. Global Influenza Vaccine Revenue Share by Type (2022-2027)
    Table 35. Influenza Vaccine Price by Type (2016-2021) & (USD/Doses)
    Table 36. Global Influenza Vaccine Price Forecast by Type (2022-2027) & (USD/Doses)
    Table 37. Global Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
    Table 38. Global Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
    Table 39. Global Influenza Vaccine Sales Share by Application (2016-2021)
    Table 40. Global Influenza Vaccine Sales Share by Application (2022-2027)
    Table 41. Global Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 42. Global Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
    Table 43. Global Influenza Vaccine Revenue Share by Application (2016-2021)
    Table 44. Global Influenza Vaccine Revenue Share by Application (2022-2027)
    Table 45. Influenza Vaccine Price by Application (2016-2021) & (USD/Doses)
    Table 46. Global Influenza Vaccine Price Forecast by Application (2022-2027) & (USD/Doses)
    Table 47. North America Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
    Table 48. North America Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
    Table 49. North America Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 50. North America Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
    Table 51. North America Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
    Table 52. North America Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
    Table 53. North America Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 54. North America Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
    Table 55. North America Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
    Table 56. North America Influenza Vaccine Sales by Country (2022-2027) & (K Doses)
    Table 57. North America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 58. North America Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 59. Europe Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
    Table 60. Europe Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
    Table 61. Europe Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 62. Europe Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
    Table 63. Europe Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
    Table 64. Europe Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
    Table 65. Europe Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 66. Europe Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
    Table 67. Europe Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
    Table 68. Europe Influenza Vaccine Sales by Country (2022-2027) & (K Doses)
    Table 69. Europe Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 70. Europe Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 71. Asia Pacific Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
    Table 72. Asia Pacific Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
    Table 73. Asia Pacific Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
    Table 75. Asia Pacific Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
    Table 76. Asia Pacific Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
    Table 77. Asia Pacific Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 78. Asia Pacific Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
    Table 79. Asia Pacific Influenza Vaccine Sales by Region (2016-2021) & (K Doses)
    Table 80. Asia Pacific Influenza Vaccine Sales by Region (2022-2027) & (K Doses)
    Table 81. Asia Pacific Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 82. Asia Pacific Influenza Vaccine Revenue by Region (2022-2027) & (US$ Million)
    Table 83. Latin America Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
    Table 84. Latin America Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
    Table 85. Latin America Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 86. Latin America Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
    Table 87. Latin America Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
    Table 88. Latin America Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
    Table 89. Latin America Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 90. Latin America Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
    Table 91. Latin America Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
    Table 92. Latin America Influenza Vaccine Sales by Country (2022-2027) & (K Doses)
    Table 93. Latin America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 94. Latin America Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 95. Middle East and Africa Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
    Table 96. Middle East and Africa Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
    Table 97. Middle East and Africa Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 98. Middle East and Africa Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
    Table 99. Middle East and Africa Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
    Table 100. Middle East and Africa Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
    Table 101. Middle East and Africa Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 102. Middle East and Africa Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
    Table 103. Middle East and Africa Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
    Table 104. Middle East and Africa Influenza Vaccine Sales by Country (2022-2027) & (K Doses)
    Table 105. Middle East and Africa Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 106. Middle East and Africa Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 107. CSL Corporation Information
    Table 108. CSL Description and Major Businesses
    Table 109. CSL Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 110. CSL Influenza Vaccine Product
    Table 111. CSL Recent Developments
    Table 112. GSK Corporation Information
    Table 113. GSK Description and Major Businesses
    Table 114. GSK Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 115. GSK Influenza Vaccine Product
    Table 116. GSK Recent Developments
    Table 117. Sanofi Pasteur Corporation Information
    Table 118. Sanofi Pasteur Description and Major Businesses
    Table 119. Sanofi Pasteur Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 120. Sanofi Pasteur Influenza Vaccine Product
    Table 121. Sanofi Pasteur Recent Developments
    Table 122. Mylan Corporation Information
    Table 123. Mylan Description and Major Businesses
    Table 124. Mylan Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 125. Mylan Influenza Vaccine Product
    Table 126. Mylan Recent Developments
    Table 127. AstraZeneca Corporation Information
    Table 128. AstraZeneca Description and Major Businesses
    Table 129. AstraZeneca Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 130. AstraZeneca Influenza Vaccine Product
    Table 131. AstraZeneca Recent Developments
    Table 132. Pfizer Corporation Information
    Table 133. Pfizer Description and Major Businesses
    Table 134. Pfizer Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 135. Pfizer Influenza Vaccine Product
    Table 136. Pfizer Recent Developments
    Table 137. Johnson & Johnson Corporation Information
    Table 138. Johnson & Johnson Description and Major Businesses
    Table 139. Johnson & Johnson Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 140. Johnson & Johnson Influenza Vaccine Product
    Table 141. Johnson & Johnson Recent Developments
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Influenza Vaccine Distributors List
    Table 145. Influenza Vaccine Customers List
    Table 146. Influenza Vaccine Market Trends
    Table 147. Influenza Vaccine Market Drivers
    Table 148. Influenza Vaccine Market Challenges
    Table 149. Influenza Vaccine Market Restraints
    Table 150. Research Programs/Design for This Report
    Table 151. Key Data Information from Secondary Sources
    Table 152. Key Data Information from Primary Sources
List of Figures
    Figure 1. Influenza Vaccine Product Picture
    Figure 2. Global Influenza Vaccine Market Share by Type in 2020 & 2027
    Figure 3. Whole Virus Vaccines Product Picture
    Figure 4. Split Virus Vaccines Product Picture
    Figure 5. Subunit Vaccines Product Picture
    Figure 6. Live Attenuated Virus Vaccines Product Picture
    Figure 7. Global Influenza Vaccine Sales Market Share by Application in 2020 & 2027
    Figure 8. For Children (6 months to 3 years)
    Figure 9. For Adults and Children over 3 years
    Figure 10. Influenza Vaccine Report Years Considered
    Figure 11. Global Influenza Vaccine Sales 2016-2027 (K Doses)
    Figure 12. Global Influenza Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Influenza Vaccine Revenue 2016-2027 (US$ Million)
    Figure 14. Global Influenza Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 15. Global Influenza Vaccine Sales Market Share by Region (2016-2021)
    Figure 16. Global Influenza Vaccine Sales Market Share by Region (2022-2027)
    Figure 17. North America Influenza Vaccine Sales YoY (2016-2027) & (K Doses)
    Figure 18. North America Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
    Figure 19. Europe Influenza Vaccine Sales YoY (2016-2027) & (K Doses)
    Figure 20. Europe Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
    Figure 21. Asia-Pacific Influenza Vaccine Sales YoY (2016-2027) & (K Doses)
    Figure 22. Asia-Pacific Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
    Figure 23. Latin America Influenza Vaccine Sales YoY (2016-2027) & (K Doses)
    Figure 24. Latin America Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
    Figure 25. Middle East & Africa Influenza Vaccine Sales YoY (2016-2027) & (K Doses)
    Figure 26. Middle East & Africa Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
    Figure 27. The Top 10 and Top 5 Players Market Share by Influenza Vaccine Sales in 2020
    Figure 28. The Top 10 and Top 5 Players Market Share by Influenza Vaccine Revenue in 2020
    Figure 29. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 30. Global Influenza Vaccine Sales Market Share by Type (2016-2027)
    Figure 31. Global Influenza Vaccine Revenue Market Share by Type (2016-2027)
    Figure 32. Global Influenza Vaccine Sales Market Share by Application (2016-2027)
    Figure 33. Global Influenza Vaccine Revenue Market Share by Application (2016-2027)
    Figure 34. North America Influenza Vaccine Sales Market Share by Type (2016-2027)
    Figure 35. North America Influenza Vaccine Revenue Market Share by Type (2016-2027)
    Figure 36. North America Influenza Vaccine Sales Market Share by Application (2016-2027)
    Figure 37. North America Influenza Vaccine Revenue Market Share by Application (2016-2027)
    Figure 38. North America Influenza Vaccine Sales Share by Country (2016-2027)
    Figure 39. North America Influenza Vaccine Revenue Share by Country (2016-2027)
    Figure 40. U.S. Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 41. Canada Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 42. Europe Influenza Vaccine Sales Market Share by Type (2016-2027)
    Figure 43. Europe Influenza Vaccine Revenue Market Share by Type (2016-2027)
    Figure 44. Europe Influenza Vaccine Sales Market Share by Application (2016-2027)
    Figure 45. Europe Influenza Vaccine Revenue Market Share by Application (2016-2027)
    Figure 46. Europe Influenza Vaccine Sales Share by Country (2016-2027)
    Figure 47. Europe Influenza Vaccine Revenue Share by Country (2016-2027)
    Figure 48. Germany Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 49. France Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 50. U.K. Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 51. Italy Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 52. Russia Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 53. Asia Pacific Influenza Vaccine Sales Market Share by Type (2016-2027)
    Figure 54. Asia Pacific Influenza Vaccine Revenue Market Share by Type (2016-2027)
    Figure 55. Asia Pacific Influenza Vaccine Sales Market Share by Application (2016-2027)
    Figure 56. Asia Pacific Influenza Vaccine Revenue Market Share by Application (2016-2027)
    Figure 57. Asia Pacific Influenza Vaccine Sales Share by Region (2016-2027)
    Figure 58. Asia Pacific Influenza Vaccine Revenue Share by Region (2016-2027)
    Figure 59. China Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 60. Japan Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 61. South Korea Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 62. India Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 63. Australia Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 64. Taiwan Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 65. Indonesia Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 66. Thailand Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 67. Malaysia Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 68. Philippines Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 69. Latin America Influenza Vaccine Sales Market Share by Type (2016-2027)
    Figure 70. Latin America Influenza Vaccine Revenue Market Share by Type (2016-2027)
    Figure 71. Latin America Influenza Vaccine Sales Market Share by Application (2016-2027)
    Figure 72. Latin America Influenza Vaccine Revenue Market Share by Application (2016-2027)
    Figure 73. Latin America Influenza Vaccine Sales Share by Country (2016-2027)
    Figure 74. Latin America Influenza Vaccine Revenue Share by Country (2016-2027)
    Figure 75. Mexico Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 76. Brazil Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 77. Argentina Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 78. Middle East and Africa Influenza Vaccine Sales Market Share by Type (2016-2027)
    Figure 79. Middle East and Africa Influenza Vaccine Revenue Market Share by Type (2016-2027)
    Figure 80. Middle East and Africa Influenza Vaccine Sales Market Share by Application (2016-2027)
    Figure 81. Middle East and Africa Influenza Vaccine Revenue Market Share by Application (2016-2027)
    Figure 82. Middle East and Africa Influenza Vaccine Sales Share by Country (2016-2027)
    Figure 83. Middle East and Africa Influenza Vaccine Revenue Share by Country (2016-2027)
    Figure 84. Turkey Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 85. Saudi Arabia Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 86. U.A.E Influenza Vaccine Revenue (2016-2027) & (US$ Million)
    Figure 87. Influenza Vaccine Value Chain
    Figure 88. Influenza Vaccine Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows multiple user to access the PDF.

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

Global Infectious Disease Diagnosis Market Size Status and Forecast 2021 2027
Global Infectious Disease Diagnosis Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10N1843
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Infectious Disease Diagnostics Testing Market Size Status and Forecast 2021 2027
Global Infectious Disease Diagnostics Testing Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Othe-2O272
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global HPV Associated Disorder Market Size Status and Forecast 2021 2027
Global HPV Associated Disorder Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-28G2646
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Hepatitis B Treatment Market Size Status and Forecast 2021 2027
Global Hepatitis B Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-34S2647
Sun Jul 18 00:00:00 UTC 2021

Add to Cart